Colorectal Cancer Screening Guidelines: The Importance of Evidence and Transparency

Gastroenterology

Volumn 138, Issue 5, 2010, Pages

  Allison, James E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HEMOGLOBIN;

ADENOMATOUS POLYP; ARTICLE; BARIUM ENEMA; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COST; FECAL IMMUNOCHEMICAL TEST; GUAIAC TEST; HEALTH CARE PLANNING; HUMAN; MEDICARE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK REDUCTION; SENSITIVITY ANALYSIS; SIGMOIDOSCOPY;

EID: 77951669260     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.03.001     Document Type: Article

References (5)

1. Levin B., Lieberman D.A., McFarland, et al. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134 (2008) 1570-1595
2. Mandel J.S., Church T.R., Bond J.H., et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343 (2000) 1603-1607
3. Allison J.E., Tekawa I.S., Ransom L.J., et al. A comparison of fecal occult blood tests for colorectal cancer screening. N Engl J Med 334 (1996) 155-159
4. Allison J.E., Sakoda L.C., Levin T.R., et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 99 (2007) 1-9
5. Morikawa T., Kato J., Yamaji Y., et al. Comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 129 (2005) 422-428